Website:
Seamaty
Seamaty
About Us
Chengdu Seamaty Technology Co., Ltd has dedicated in the medical and veterinary diagnostic field since 2012, providing point of care testing (POCT) medical equipment worldwide. We have passed ISO 13485:2016 international quality management system certification. Our factory has equipped with full-automatic production lines plus our professional quality control team to ensure high productivity and premium quality of products. Seamaty has 9 subsidiaries in Shenzhen, Germany, Russia, Thailand, Singapore, Egypt, Turkey, Brazil, and Poland while worked with dozens of partners around the world, and you could find our products and services in more than 100 countries and regions.
Company Size:
1、Focus on point-of-care testing for 12 years, providing diagnostic solutions for the medical and veterinary.
2、Office and production size over 10000 ㎡ with production lines for biochemistry products and blood gas & electrolyte products.
3、Have a young, professional and innovative team with R&D personnel more than 20% of total employees.
4、Seamaty has 9 subsidiaries. Headquartered in Chengdu, China. We have 2 domestic subsidiaries, 7 overseas subsidiaries, and 2 R&D centers.
Company History:
2012 Chengdu Seamaty Technology Co. , Ltd. was founded on August 30,2012.
2013 The company has successfully developed the prototype and obtained two patents for invention and a number of patents for utility models.
2014 The company accepted the investment of Nanjing Perlong Group, the high-standard purification workshop was established.
2015 Chengdu Polytech Biological Technology Co. , Ltd. was established. Seamaty obtained a medical device quality management system certification.
2016 Products have passed the European Union Medical Device CE certification, and received the “National high-tech Enterprises” qualification.
2017 Chemiimmunoluminescence analyzer approved, at the same time, the company has obtained the certification of intellectual property management system.
2018 The company moved to the new office, built a GMP production workshop, and won the A round of financing.
2019 The biochemistry analyzer has been registered and officially launched in China, and our products are used in 40% of veterinary clinics and animal hospitals in China.
2020 Set up branch office and R&D Center in Shenzhen and overseas branch office in Germany.
2021 Began to develop blood gas & electrolyte analyzer and received Series B funding.
2022 Establishment of a Thai subsidiary; Establishment of a Russian subsidiary; Establishment of a Singapore subsidiary; Establishment of a Turkish subsidiary; Establishment of an Egyptian subsidiary; Establishment of Brazilian subsidiary.
2023 Launch Future Medical Manufacturing Base Project in Sichuan, China.
